The Drug Cost Controversy, Part 1: Legal vs. Ethical

Description

While many expressed outrage over high-profile drug pricing cases like those of EpiPen and colchicine, costs continue to rise—with no sign of relief. What’s more, all current pricing conforms with current laws. We’ll examine these laws closely, and you’ll see how they may contribute to high prices. 

Pharmacist Learning Objectives

At the completion of this knowledge-based activity, participants will be able to: 

  1. Review the development and current role of manufacturers and pharmacy benefit managers (PBMs) in the drug pricing controversy.
  2. Describe the role and authority of government agencies, including state agencies, and their efforts to address drug price increases. 
  3. Review the Trump Administration’s efforts to implement the policies described in the Blueprint to Lower Drug Prices. 
  4. Describe the implications of different legislative proposals and lawsuits related to drug pricing. 

Technician Learning Objectives

At the completion of this knowledge-based activity, participants will be able to: 

  1. Review the development and current role of manufacturers and pharmacy benefit managers (PBMs) in the drug pricing controversy.
  2. Describe the role and authority of government agencies, including state agencies, and their efforts to address drug price increases. 
  3. Review the Trump Administration’s efforts to implement the policies described in the Blueprint to Lower Drug Prices. 
  4. Describe the implications of different legislative proposals and lawsuits related to drug pricing. 
 
 
 
Speakers:
Francis
Francis Palumbo, FAPhA
Executive Director Center on Drugs & Public Policy
University of Maryland School of Pharmacy
 
Lee
Lee Rosebush,
Partner
Baker Hostetler LLP
 
Learning Level: Level 2
Track: Pharmacy Law and Regulations
Session Time Slot(s): 
Date: 
Sunday, March 22
Time: 
1:00 PM - 2:15 PM
Room: 
Gaylord National Resort - National Harbor 10-11
CEUs Pharmacist: 0.125
CEUs Pharmacy Technician: 0.125
Activity Type:
Knowledge-based